Fostamatinib OverviewFostamatinib, sold under the brand names Tavalisse and Tavlesse, is a medication approved by the U.S. Food and Drug Administration since 2018 and European Medicines Agency since 2020 for the treatment of chronic immune thrombocytopenia (ITP). The drug is administered orally as a disodium hexahydrate salt, and is a prodrug of the active compound tamatinib (R-406), which is an inhibitor of the enzyme spleen tyrosine kinase (Syk), hence i...
Read more Fostamatinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fostamatinib
Recent Fostamatinib Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 100mg, 150mg